Is Tech The Answer For Seizure Patients?

Is Tech The Answer For Seizure Patients?

According to the CDC, over 3.4 million Americans – or 1.2 percent of the U.S. population – suffer from some form of epilepsy. Medication keeps some of these people’s seizures under control. The medications’ side effects, however, often make it difficult to function normally, and at least 30 percent of patients don’t respond to anti-seizure medication at all.

Enter NeuroPace, Inc., a neuro-technology company based in Silicon Valley. It recently concluded a nine-year study on patients suffering from epilepsy using a tech gadget – not medication – to stymie the seizures.

The results? Over the course of the study, 75 percent of epileptic patients had at least a 50 percent reduction in seizures – and 33 percent had at least a 90 percent reduction! In addition, 28 percent had no seizures for over six months and 18 percent had no seizures for over a year. Patients did not report chronic stimulation side effects.

NeuroPace’s neuro-modulation study was the longest and largest for epileptics. The company evaluated 230 patients from 33 epilepsy centers across the United States. In addition to long-term seizure reduction, patients reported having a better quality of life in areas unrelated to epilepsy, and the device’s neural recordings provided doctors with critical information to better understand and, subsequently, treat seizures.

So how exactly does the technology work?

Neurons in the human brain constantly release electrical signals (otherwise known as brain activity). Misfired electrical signals can result in seizures. Anti-seizure medications remove, reduce, or alter excessive electrical activity so that faulty electrical signals aren’t “passed on” to the next batch of neurons, thus reducing the probability of seizures.

In contrast, NeuroPace’s Responsive Neurostimulation (RNS) System uses a computer interface technology device to treat the seizures at their source – and the device only goes into gear when the patient requires it. The RNS System uses a three-pronged approach. First, it detects and responds to a patient’s brain activity. Every patient’s brain is a little different, so doctors tailor the program to each patient’s unique brain activity.

Once programmed, the RNS System monitors a patient’s brainwaves and is ready to provide treatment whenever it detects unusual activity that can lead to a seizure, even if the patient is sleeping. Finally, once unusual brain activity is detected, the device responds with a series of electrical pulses or bursts of stimulation to stop the seizure and normalize the brainwaves before the seizure begins.

The RNS device, which is essentially a neuro-stimulator, is placed on the bone covering the brain. Once installed, it cannot be seen or felt. Tiny wires are positioned on one or two places atop the brain where seizure activity is likely to occur. The RNS System has a remote monitor used by patients to upload his or her data, as well as an RNS tablet and Patient Data Management System to enable doctors to better monitor patients. The device can always be turned off or removed if a patient doesn’t want it anymore.

During the course of the study, NeuroPace upgraded its RNS System. The 2.0 version has a battery life lasting 8.4 years, as opposed to the original’s 3.9 years. The amount of available memory for doctors to review patients’ brainwaves has also doubled.

The RNS System is available in epilepsy centers across the U.S. It is often used in conjunction with medication and is usually covered by insurance.

SOURCE: Article by B. Halperin for

Implantable Device Provides New Treatment Option for Epilepsy Patients

Implantable Device Provides New Treatment Option for Epilepsy Patients

Richard Pollitt was at the end of his rope after years of suffering regular seizures, with some lasting five minutes and preventing him from working and enjoying his favorite pastimes. Desperate for relief after medications did not work, Pollitt had a small battery-powered device implanted in his skull to control seizures. Now he rarely has them.

Photo Credit: Houston Methodist
After experiencing four to five seizures a week for six years, Richard Pollitt, left, had a device implanted in his brain to help prevent seizures. The device provides data that allows his physician, Houston Methodist neurologist Amit Verma, M.D., right, to track the activity of his brain and the device to improve care.


First RNS Patient in the South Doing Well 30 Days Later

First RNS Patient in the South Doing Well 30 Days Later


Neurologists implant neurostimulator in brain to control seizures

It has been 30 days since neurologists at the University of Alabama at Birmingham turned on the neurostimulator implanted in Sarah Conner’s brain to control her seizures.

In that short time, she can already say, “I’m doing pretty good.”

Conner, 24, has suffered from seizures for 10 years. In June, she became the first patient in the Southeast to receive a new device called a responsive neurostimulator since its approval by the Federal Drug Administration last year.

UAB neurosurgeon Kristen Riley, M.D., implanted the RNS system, developed by NeuroPace, into Conner’s brain. It includes an electrical generator, about the size of a flash drive, which is implanted in the skull. Electrodes are run to the locations in the brain known to cause seizures.

“It is designed to record a patient’s specific brain activity and recognize patterns that are associated with seizures,” said Riley, associate professor in the Department of Neurosurgery. “The RNS system then delivers stimulation in order to help modulate and control the seizures.”

Prior to receiving the RNS system, Conner experienced multiple semi-partial seizures every day, lasting anywhere from 10 seconds to more than a minute. When they hit, she lost all ability to function.

“It affected my motor function and sensory perception,” Conner said. “I couldn’t tell where my hand was, for instance. I couldn’t even do simple functions such as open a door because my body wouldn’t respond. It was as if I’d forgotten how to do it.”

A month after the surgery, UAB neurologist Neil Billeaud, M.D., turned on the device. At a follow-up visit 30 days later, Conner reported dramatic improvement.

“I used to have several seizures every day; but now that I have the stimulator, I get a little flash, maybe once every other day,” she said. “The flash lasts just a second or two and then it’s gone.”

The RNS system is constantly recording Conner’s brain activity, and the data is downloaded to a laptop computer. If Conner says she had a flash last week, Billeaud can pinpoint the specific time and see what brain activity was occurring. As the system learns more about specific patterns that indicate a seizure is likely, Billeaud can tweak the parameters to make the RNS system even more effective in controlling seizures.

Jerzy Szaflarski, M.D., Ph.D., professor in the Department of Neurology and director of the UAB Epilepsy Center, says data from research studies dating back several years indicate that many patients will respond to the stimulation and have significant reduction in their seizures.

“This is not a treatment that will cure epilepsy,” he said. “This is a treatment that will help control seizures in a very specific group of patients who otherwise are not candidates for surgery. I don’t expect too many patients to become seizure-free; but if we can decrease their seizures by even half, we can make huge improvements in their lives.”

Conner agrees. She is working on a degree in elementary education and had episodes in the past in which she had a seizure while student-teaching. The reduction in seizures will give her more independence.

“I’ll be able to do more,” Conner said. “For instance, I’ll be able to drive. I’m 24, and I’ve never driven a car. The big hindrance with the seizures was that, when they hit, I couldn’t function and was unable to do anything. Now I simply feel this flash, and then it goes away without affecting my motor function.”

The RNS system is for patients who have severe seizures but do not respond to medications and are not candidates for surgery because the location of their seizure onset is at a sensitive part of the brain. It is also only for patients whose seizure onset can be traced to just one or two locations in the brain.

“We’re very excited to offer this therapy to our patients who are not candidates for more traditional therapies for epilepsy,” Szaflarski said. “We see multiple patients like that every year, and the RNS system could make a huge difference in the lives of those patients. There is already data to show that the quality of life of those patients has improved significantly with RNS.”



WHAT’S THAT? Nerve Stimulation In Ear Could Improve Heart Heath

WHAT’S THAT? Nerve Stimulation In Ear Could Improve Heart Heath

earStimulating nerves in your ear could improve the health of your heart, researchers have discovered.

A team at the University of Leeds used a standard TENS machine like those designed to relieve labour pains to apply electrical pulses to the tragus, the small raised flap at the front of the ear immediately in front of the ear canal.

The stimulation changed the influence of the nervous system on the heart by reducing the nervous signals that can drive failing hearts too hard.

Professor Jim Deuchars, Professor of Systems Neuroscience in the University of Leeds’ Faculty of Biological Sciences, said: “You feel a bit of a tickling sensation in your ear when the TENS machine is on, but it is painless. It is early days-so far we have been testing this on healthy subjects-but we think it does have potential to improve the health of the heart and might even become part of the treatment for heart failure.”

The researchers applied electrodes to the ears of 34 healthy people and switched on the TENS (Transcutaneous electrical nerve stimulation) machines for 15-minute sessions. They monitored the variability of subjects’ heartbeats and the activity of the part of the nervous system that drives the heart. Monitoring continued for 15 minutes after the TENS machine was switched off. (more…)